中文
Tengxiang Import and Export focuses on the production and process technology services of pharmaceutical intermediates, and focuses on the industrialization of azo reagents for Mitsunobu reactions. This issue focuses on the systematic process analysis of the popular reagent azodicarboxylate di tert butyl ester in the industry:
In the field of industrial raw material (API) synthesis, di tert butyl azodicarboxylate (DBAD, CAS number: 870-50-8) has become a high-value synthetic reagent due to its solid-state physicochemical properties and the advantage of simplifying the refining process of finished APIs. Compared to traditional reagents such as diethyl azodicarboxylate (DEAD), DBAD can significantly avoid many high-risk thermal decomposition risks and material toxicity hazards.
Industrial amplification of production advantages
1. Easy purification and refinement: The reaction byproduct, di tert butyl hydrazine dicarboxylate, is extremely unstable to acid and can be removed by extraction and washing with dilute acid aqueous solution, without the need for expensive large-scale column chromatography equipment.
2. Higher safety of use: Liquid DEAD is prone to detonation under impact and is only suitable for use in solution systems; DBAD is a stable crystalline solid with clear thermal decomposition parameters, which facilitates safety production control in pilot workshops and kilogram level laboratories.
3. Good compatibility of reagent combination: It is usually used in conjunction with triphenylphosphine (PPh3) for Mitsunobu reaction, which can achieve high selectivity in secondary alcohol configuration inversion or construct carbon oxygen, carbon nitrogen, and carbon sulfur bonds while being compatible with multiple functional groups.
Difficulties and precautions in industrial application
1. Difficulties in by-product recovery: Although the purification difficulty of the product is low, the reaction will generate triphenylphosphine oxide (TPPO) and hydrazine dicarboxylate by-products according to stoichiometry, which require continuous condensation process or layered extraction optimization for post-treatment.
2. Reaction temperature control requirements: Although the safety is better than that of liquid azodicarboxylate reagents, large-scale production has significant heat release, and intermittent reaction vessels require precise speed control and sufficient cooling systems.
General Industrial Post Processing Operating Procedures
The general process steps for mass production are as follows:
1. Feeding preparation: Under inert gas protection, dissolve alcohol raw materials, nucleophilic precursors (phenol, carboxylic acid materials), and triphenylphosphine in tetrahydrofuran (THF) or toluene solvent.
2. Batch feeding: Solid DBAD is added in batches, and the system is temperature controlled from 0 ℃ to room temperature to suppress the intense exothermic reaction in the initial stage.
3. Reaction quenching: Add water to terminate the reaction, remove the original solvent or replace the solvent with ethyl acetate.
4. Removal of hydrazine by-products: The feed solution is washed with acidic aqueous solutions such as hydrochloric acid. The hydrazine compounds, as by-products, undergo protonation and enter the aqueous phase for separation. The target active pharmaceutical ingredient remains in the organic phase.
5. Refining and purification: Residual triphenylphosphine oxide is removed through recrystallization and precision filtration to ensure product purity meets the requirements of current Good Manufacturing Practice (cGMP) for pharmaceuticals.
Tengxiang Import and Export can provide stable supply of high-purity DBAD. If there is a demand for sample procurement or industrial mass production projects, we can connect with Tengxiang Service Team and rely on the dual advantages of process empowerment and mass production support to help pharmaceutical companies simplify refining processes, avoid production safety hazards, and solve practical problems in raw material drug synthesis in one stop.